Radial extracorporeal shock wave therapy for the management of spasticity in cerebral palsy: a randomized controlled trial with different time intervals between sessions - Report - MDSpire
Advertisement
Radial extracorporeal shock wave therapy for the management of spasticity in cerebral palsy: a randomized controlled trial with different time intervals between sessions
Clinical Report: Radial Extracorporeal Shock Wave Therapy for Spasticity Management
Overview
This study evaluates the efficacy of radial extracorporeal shock wave therapy (rESWT) for managing spasticity in cerebral palsy, comparing different intervals between treatment sessions. All groups showed significant improvements in muscle stretch and functional mobility, with no significant differences based on treatment frequency.
Background
Spasticity is the most common motor disorder in cerebral palsy (CP), affecting mobility and quality of life. Effective management of spasticity is crucial for improving functional outcomes in patients with CP. Radial extracorporeal shock wave therapy (rESWT) presents a non-invasive treatment option, yet optimal administration protocols remain unclear.
Data Highlights
Outcome Measure
Group 1 (1-week interval)
Group 2 (2-week interval)
Group 3 (4-week interval)
Passive Range of Motion
Significant Improvement
Significant Improvement
Significant Improvement
Catch Angle
Significant Improvement
Significant Improvement
Significant Improvement
Timed Up and Go Test
Significant Improvement
Significant Improvement
Significant Improvement
10-Meter Walk Test
Significant Improvement
Significant Improvement
Significant Improvement
Key Findings
All treatment groups showed significant improvements in passive range of motion (p < 0.001).
No significant differences were found between groups regarding treatment intervals.
Younger patients exhibited a greater treatment response (p < 0.001).
Functional mobility improved across all groups, with no significant group–time interactions.
rESWT can be administered with flexible intervals without compromising therapeutic effects.
Clinical Implications
Clinicians may consider rESWT as a viable option for managing spasticity in CP, allowing for flexibility in treatment scheduling. The findings support the use of rESWT regardless of the interval between sessions, which can be tailored to patient needs.
Conclusion
The study indicates that rESWT is effective in improving spasticity-related outcomes in CP, with no significant impact from varying treatment intervals. This flexibility may enhance patient adherence and accessibility to therapy.
A prespecified exploratory analysis of the FIND-CKD clinical trial examined kidney function, albuminuria, and kidney failure outcomes in 903 patients with glomerular diseases.